Previous Article | Next Article 
Infection and Immunity, January 2004, p. 247-252, Vol. 72, No. 1
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.1.247-252.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Association between Protection against Clinical Malaria and Antibodies to Merozoite Surface Antigens in an Area of Hyperendemicity in Myanmar: Complementarity between Responses to Merozoite Surface Protein 3 and the 220-Kilodalton Glutamate-Rich Protein
Soe Soe,1,2,
Michael Theisen,3,4,
Christian Roussilhon,1 Khin-Saw- Aye,2 and Pierre Druilhe1*
BioMedical Parasitology Unit, Pasteur Institute, Paris, France,1
Department of Medical Research, Yangon, Myanmar,2
Departments of Clinical Biochemistry,3
Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark4
Received 28 March 2003/
Returned for modification 20 May 2003/
Accepted 6 October 2003
We performed a longitudinal clinical and parasitological follow-up study in OoDo, a village in southeast Asia in which malaria is hyperendemic, in order to assess the association between protection against malaria attacks and antibodies to three currently evaluated vaccine candidates, merozoite surface protein 1 (MSP1), MSP3, and the 220-kDa glutamate-rich protein (GLURP) from Plasmodium falciparum. Our results showed that the levels of cytophilic immunoglobulin G3 (IgG3) antibodies against conserved regions of MSP3 and GLURP were significantly correlated with protection against clinical P. falciparum malaria. In contrast, the levels of noncytophilic IgG4 antibodies against GLURP increased with the number of malaria attacks. Furthermore, we observed a complementary effect of the MSP3- and GLURP-specific IgG3 antibodies in relation to malaria protection. In the individuals that did not respond to one of the antigens, a strong response to the other antigen was consistently detected and was associated with protection, suggesting that induction of antibodies against both MSP3 and GLURP could be important for the development of protective immunity. The complementarity of the responses to the two main targets of antibody-dependent cellular inhibition identified to date provides the first rational basis for combining these two antigens in a hybrid vaccine formulation.
* Corresponding author. Mailing address: Unité de Parasitologie Bio-Médicale, Institut Pasteur, 25 Rue du Dr. Roux, 75015 Paris, France. Phone: 331 45 68 85 78. Fax: 331 45 68 86 40. E-mail:
druilhe{at}pasteur.fr.
Editor: J. M. Mansfield
S.S. and M.T. contributed equally to this work.
Infection and Immunity, January 2004, p. 247-252, Vol. 72, No. 1
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.1.247-252.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Osier, F. H. A., Fegan, G., Polley, S. D., Murungi, L., Verra, F., Tetteh, K. K. A., Lowe, B., Mwangi, T., Bull, P. C., Thomas, A. W., Cavanagh, D. R., McBride, J. S., Lanar, D. E., Mackinnon, M. J., Conway, D. J., Marsh, K.
(2008). Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria. Infect. Immun.
76: 2240-2248
[Abstract]
[Full Text]
-
Nebie, I., Diarra, A., Ouedraogo, A., Soulama, I., Bougouma, E. C., Tiono, A. B., Konate, A. T., Chilengi, R., Theisen, M., Dodoo, D., Remarque, E., Bosomprah, S., Milligan, P., Sirima, S. B.
(2008). Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal Malaria Transmission in Burkina Faso, West Africa. Infect. Immun.
76: 759-766
[Abstract]
[Full Text]
-
Jafarshad, A., Dziegiel, M. H., Lundquist, R., Nielsen, L. K., Singh, S., Druilhe, P. L.
(2007). A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes Fc{gamma}RII and Fc{gamma}RIII. J. Immunol.
178: 3099-3106
[Abstract]
[Full Text]
-
Lundquist, R., Nielsen, L. K., Jafarshad, A., SoeSoe, D., Christensen, L. H., Druilhe, P., Dziegiel, M. H.
(2006). Human Recombinant Antibodies against Plasmodium falciparum Merozoite Surface Protein 3 Cloned from Peripheral Blood Leukocytes of Individuals with Immunity to Malaria Demonstrate Antiparasitic Properties.. Infect. Immun.
74: 3222-3231
[Abstract]
[Full Text]
-
BOUSEMA, J. T., ROEFFEN, W., VAN DER KOLK, M., DE VLAS, S. J., VAN DE VEGTE-BOLMER, M., BANGS, M. J., TEELEN, K., KURNIAWAN, L., MAGUIRE, J. D., BAIRD, J. K., SAUERWEIN, R. W.
(2006). RAPID ONSET OF TRANSMISSION-REDUCING ANTIBODIES IN JAVANESE MIGRANTS EXPOSED TO MALARIA IN PAPUA, INDONESIA.. Am J Trop Med Hyg
74: 425-431
[Abstract]
[Full Text]
-
Tongren, J. E., Drakeley, C. J., McDonald, S. L. R., Reyburn, H. G., Manjurano, A., Nkya, W. M. M., Lemnge, M. M., Gowda, C. D., Todd, J. E., Corran, P. H., Riley, E. M.
(2006). Target Antigen, Age, and Duration of Antigen Exposure Independently Regulate Immunoglobulin G Subclass Switching in Malaria. Infect. Immun.
74: 257-264
[Abstract]
[Full Text]
-
Audran, R., Cachat, M., Lurati, F., Soe, S., Leroy, O., Corradin, G., Druilhe, P., Spertini, F.
(2005). Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen. Infect. Immun.
73: 8017-8026
[Abstract]
[Full Text]
-
PRATT-RICCIO, L. R., LIMA-JUNIOR, J. C., CARVALHO, L. J. M., THEISEN, M., ESPINDOLA-MENDES, E. C., SANTOS, F., OLIVEIRA-FERREIRA, J., GOLDBERG, A. C., DANIEL-RIBEIRO, C. T., BANIC, D. M.
(2005). ANTIBODY RESPONSE PROFILES INDUCED BY PLASMODIUM FALCIPARUM GLUTAMATE-RICH PROTEIN IN NATURALLY EXPOSED INDIVIDUALS FROM A BRAZILIAN AREA ENDEMIC FOR MALARIA. Am J Trop Med Hyg
73: 1096-1103
[Abstract]
[Full Text]